CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).

MLA

Aran, Gemma, et al. “CD5L Is Upregulated in Hepatocellular Carcinoma and Promotes Liver Cancer Cell Proliferation and Antiapoptotic Responses by Binding to HSPA5 (GRP78).” FASEB Journal, vol. 32, no. 7, July 2018, pp. 3878–91. EBSCOhost, https://doi.org/10.1096/fj.201700941RR.

APA

Aran, G., Sanjurjo, L., Bárcena, C., Simon-Coma, M., Téllez, É., Vázquez-Vitali, M., Garrido, M., Guerra, L., Díaz, E., Ojanguren, I., Elortza, F., Planas, R., Sala, M., Armengol, C., & Sarrias, M.-R. (2018). CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). FASEB Journal, 32(7), 3878–3891. https://doi.org/10.1096/fj.201700941RR

Chicago

Aran, Gemma, Lucía Sanjurjo, Cristina Bárcena, Marina Simon-Coma, Érica Téllez, Maria Vázquez-Vitali, Marta Garrido, et al. 2018. “CD5L Is Upregulated in Hepatocellular Carcinoma and Promotes Liver Cancer Cell Proliferation and Antiapoptotic Responses by Binding to HSPA5 (GRP78).” FASEB Journal 32 (7): 3878–91. doi:10.1096/fj.201700941RR.